General - Press Releases

Date	Title	Company
11-Dec-2023	Kramer Levin Elevates Five to Counsel and Three to Special Counsel	Businesswire
11-Dec-2023	Middle East & Africa Construction Industry Report 2023: Saudi Arabia is Projected to be at the Forefront of Investments - ResearchAndMarkets.com	Businesswire
11-Dec-2023	Daido Steel Accelerates Materials Design and Qualification with ICMD® SaaS Platform from QuesTek	Businesswire
11-Dec-2023	Corsair Pharma Announces Appointment of George W. Mahaffey as Chief Executive Officer	Businesswire
11-Dec-2023	Menarini Group Presented Initial Safety and Efficacy Data from Phase 1b/2 ELEVATE and ELECTRA Combination Studies of ORSERDU® (Elacestrant) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2023 San Antonio Breast Cancer Symposium	Businesswire
11-Dec-2023	Glycomine Announces First Pediatric Patient Dosed in Phase 2 Clinical Study of GLM101, a Potential Treatment for PMM2-CDG	Businesswire
11-Dec-2023	Aptar Pharma Continues Global Expansion Program with Opening of New Mumbai Site	Aptar Pharma
11-Dec-2023	Puma Biotechnology Announces Phase II Clinical Trial Design for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer	Businesswire
11-Dec-2023	Synchron Appoints Andy Rasdal to Board of Directors	Businesswire
11-Dec-2023	Shape Memory Medical Announces Sublicense of Intellectual Property	Businesswire
11-Dec-2023	Thermo Fisher Scientific Introduces New Sample Preparation Solutions to Simplify and Automate Respiratory Diagnostic Testing	Businesswire
11-Dec-2023	Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients	Businesswire
11-Dec-2023	Takara Bio USA Wins EU Opposition Hearing, Revoking Jumpcode Genomics’ NGS Library Enrichment Patent	Businesswire
11-Dec-2023	United States Syringes & Needles Market Insights Report 2023: A $10.87 Billion Market by 2028 with BD, ICU Medical, Nipro Medical, Terumo, and Cardinal Health Emerging as Prominent Players - ResearchAndMarkets.com	Businesswire
11-Dec-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
11-Dec-2023	Electra Therapeutics presents first clinical data from ongoing Phase 1b study of ELA026 for treatment of secondary hemophagocytic lymphohistiocytosis (sHLH)	Businesswire
11-Dec-2023	Electra Therapeutics Appoints Kathy Dong, PharmD, MBA, as President and Chief Executive Officer	Businesswire
11-Dec-2023	Merck Animal Health Receives Positive CVMP Opinion for an Injectable Formulation of BRAVECTO® (Fluralaner) for Use in Dogs	Businesswire
11-Dec-2023	Merck and Moderna Initiate INTerpath-002, a Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Certain Types of Resected Non-Small Cell Lung Cancer	Businesswire
11-Dec-2023	Cytovance Biologics and Alcami Unite to Deliver End-to-End Solutions for Biologics Developers	Businesswire